Business Services Industry

Cambridge, Mass., Biotech Drug Firm Lands $50 Million in Venture Funding.

Knight Ridder/Tribune Business News, April, 2004

By Beth Healy, The Boston Globe Knight Ridder/Tribune Business News

Apr. 6--Archemix Corp., a private drug-development start-up in Cambridge, has landed $50 million in venture capital, providing fresh evidence that investors and venture firms are eager to fund hot biotech companies.

With its second round of funding in hand, Archemix has raised more than $100 million since its founding in 2001. It's a lavish sum and a harbinger of the success Highland Capital Partners and several other venture capitalists are betting that promising therapies will bring. The deal is expected to be announced today.

"These guys are good drug hunters, with a good record of identifying candidates," said Corey Mulloy, principal at Highland Capital in...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement